论文信息 - OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk - 字舞流文

OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk

G. Morgan | W. Gregory | M. Drayson | M. Jenner | F. Davies | G. Cook | D. Cairns | M. Kaiser | A. Rawstron | R. Owen | C. Pawlyn | John R. Jones | R. Tute | A. Hockaday | G. Jackson | R. Henderson | T. Menzies